T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRE
1551
DELISTED
PARTNERRE LTD
PRE
| $2.39M | ﹤0.01% |
18,600
+1,800
| +11% | +$232K |
|
1552
Synopsys
SNPS
$78.8B
| $2.38M | ﹤0.01% |
47,062
-306
| -0.6% | -$14.9K |
|
|
CPN
1553
DELISTED
Calpine Corporation
CPN
| $2.38M | ﹤0.01% |
132,199
-582,370
| -81% | -$12.1M |
|
1554
Inogen
INGN
$154M
| $2.33M | ﹤0.01% |
52,223
-27,779
| -35% | -$1.07M |
|
|
PBPB
1555
DELISTED
Potbelly
PBPB
| $2.33M | ﹤0.01% |
190,080
+794
| +0.4% | +$11.1K |
|
|
NWHM
1556
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $2.32M | ﹤0.01% |
134,630
-638,040
| -83% | -$10.1M |
|
1557
HNI Corp
HNI
$3.56B
| $2.3M | ﹤0.01% |
44,880
+1,800
| +4% | +$92.9K |
|
1558
Bio-Techne
TECH
$11.2B
| $2.28M | ﹤0.01% |
92,772
+16,280
| +21% | +$407K |
|
|
ALDR
1559
DELISTED
Alder Biopharmaceuticals
ALDR
| $2.28M | ﹤0.01% |
+43,000
| New | +$1.56M |
|
1560
Liberty Media Series A
FWONA
$23.7B
| $2.27M | ﹤0.01% |
93,473
-88
| -0.1% | -$2.27K |
|
1561
Annaly Capital Management
NLY
$17.6B
| $2.23M | ﹤0.01% |
60,605
-3,075
| -5% | -$124K |
|
1562
Voya Financial
VOYA
$9.16B
| $2.21M | ﹤0.01% |
47,500
+700
| +1% | +$31.5K |
|
1563
AGNC Investment
AGNC
$13B
| $2.2M | ﹤0.01% |
119,770
-100
| -0.1% | -$2.06K |
|
1564
Mid-America Apartment Communities
MAA
$15.6B
| $2.19M | ﹤0.01% |
30,132
-2,809
| -9% | -$212K |
|
1565
W.P. Carey
WPC
$16.3B
| $2.19M | ﹤0.01% |
37,930
+3,573
| +10% | +$223K |
|
|
CBI
1566
DELISTED
Chicago Bridge & Iron Nv
CBI
| $2.18M | ﹤0.01% |
43,569
+40
| +0.1% | +$2.08K |
|
1567
ResMed
RMD
$32.9B
| $2.16M | ﹤0.01% |
38,314
+146
| +0.4% | +$9.21K |
|
|
CYN
1568
DELISTED
CITY NATIONAL CORPORATION
CYN
| $2.12M | ﹤0.01% |
23,450
| – | – |
|
1569
Crawford & Co Class B
CRD.B
$585M
| $2.1M | ﹤0.01% |
249,228
+3,500
| +1% | +$28.5K |
|
|
EMWP
1570
DELISTED
Eros Media World PLC
EMWP
| $2.1M | ﹤0.01% |
+4,175
| New | +$1.62M |
|
1571
Reinsurance Group of America
RGA
$16.4B
| $2.09M | ﹤0.01% |
22,020
| – | – |
|
1572
Arch Capital
ACGL
$33.5B
| $2.08M | ﹤0.01% |
93,369
+4,020
| +4% | +$85.3K |
|
1573
Magnite
MGNI
$3.53B
| $2.08M | ﹤0.01% |
+138,685
| New | +$2.39M |
|
|
Y
1574
DELISTED
Alleghany Corp
Y
| $2.08M | ﹤0.01% |
4,426
| – | – |
|
1575
UGI
UGI
$7.56B
| $2.07M | ﹤0.01% |
60,140
-3,950
| -6% | -$140K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.